Guangyi Jiang

462 total citations
24 papers, 328 citations indexed

About

Guangyi Jiang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Guangyi Jiang has authored 24 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Guangyi Jiang's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Guangyi Jiang is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Guangyi Jiang collaborates with scholars based in China, Singapore and United States. Guangyi Jiang's co-authors include Xiujun Cai, Xiaolong Liu, Yu Pan, Di Wu, Yifan Wang, Ke Chen, Hendi Maher, Xiao Liang, Junliang Li and Jian Yu and has published in prestigious journals such as Journal of the American Chemical Society, Brain Research and Small.

In The Last Decade

Guangyi Jiang

21 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangyi Jiang China 9 125 125 78 63 54 24 328
Mitsuyoshi Okazaki Japan 11 132 1.1× 144 1.2× 56 0.7× 64 1.0× 95 1.8× 47 363
Annabella Di Mauro Italy 12 158 1.3× 155 1.2× 90 1.2× 46 0.7× 41 0.8× 41 401
Guoxiang Fu China 11 100 0.8× 93 0.7× 41 0.5× 56 0.9× 35 0.6× 26 284
Yu–Fu Su Taiwan 9 121 1.0× 74 0.6× 51 0.7× 61 1.0× 72 1.3× 16 298
Yingwei Zhu China 11 129 1.0× 73 0.6× 67 0.9× 53 0.8× 33 0.6× 30 302
Qing Yuan China 12 157 1.3× 53 0.4× 90 1.2× 76 1.2× 40 0.7× 42 391
Yunhong Tian China 10 123 1.0× 106 0.8× 77 1.0× 76 1.2× 77 1.4× 29 307
Zhijian Ren China 11 125 1.0× 183 1.5× 63 0.8× 64 1.0× 64 1.2× 24 382
Alessio Degiovanni Italy 12 121 1.0× 107 0.9× 70 0.9× 85 1.3× 53 1.0× 23 345
Susrutha K. Wickremesekera New Zealand 9 212 1.7× 228 1.8× 108 1.4× 78 1.2× 85 1.6× 17 448

Countries citing papers authored by Guangyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Guangyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyi Jiang more than expected).

Fields of papers citing papers by Guangyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyi Jiang. The network helps show where Guangyi Jiang may publish in the future.

Co-authorship network of co-authors of Guangyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyi Jiang. A scholar is included among the top collaborators of Guangyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyi Jiang. Guangyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Jinlong, Xin Dai, Lu Sun, et al.. (2025). Personalized Cancer-Specific Protein-Aptamer Corona for Orthogonal Multiplex Cancer Diagnosis. Journal of the American Chemical Society. 147(44). 40664–40675.
2.
Zhu, Jianqing, Guangyi Jiang, Jie Tang, et al.. (2025). SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study. International Journal of Gynecological Cancer. 35(2). 101706–101706. 1 indexed citations
3.
Feng, Dongdong, Dongxue Hu, Fangfang Xu, et al.. (2025). Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells. International Immunopharmacology. 166. 115577–115577.
4.
Liu, Yi, Haichao Zhou, Guangyi Jiang, et al.. (2025). Spatially resolved proteomics surveys the chemo‐refractory proteins related to high‐grade serous ovarian cancer. Clinical and Translational Medicine. 15(7). e70422–e70422. 1 indexed citations
5.
Wang, Ya, Jie Chen, Sen Zhang, et al.. (2024). Bispecific Nanobody‐Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors. Small. 20(25). e2308265–e2308265. 11 indexed citations
6.
Jiang, Guangyi, et al.. (2023). T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo. Journal of Cancer Research and Clinical Oncology. 149(12). 10189–10201. 6 indexed citations
7.
Jiang, Guangyi, et al.. (2023). Pupil centre’s localization with transformer without real pupil. Multimedia Tools and Applications. 82(16). 25467–25484. 4 indexed citations
8.
Liu, Kaining, et al.. (2023). Study on the effect of dynamic stiffness of supporting structure on dynamic characteristics of the rotor system. Proceedings of the Institution of Mechanical Engineers Part C Journal of Mechanical Engineering Science. 237(22). 5273–5285. 5 indexed citations
9.
Jiang, Guangyi, et al.. (2023). Glycolysis regulation in tumor‐associated macrophages: Its role in tumor development and cancer treatment. International Journal of Cancer. 154(3). 412–424. 11 indexed citations
10.
Jiang, Guangyi, et al.. (2022). Evolution of Immunotherapy for Ovarian Cancer from a Bird’s-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics. Frontiers in Oncology. 12. 795129–795129. 6 indexed citations
11.
Jiang, Guangyi, Yu Yang Ng, Johan Chin-Kang Tay, et al.. (2022). Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis. Cancer Immunology Immunotherapy. 72(1). 223–234. 22 indexed citations
12.
13.
Liu, Hui, Xia Jiang, Liying Chen, et al.. (2020). Association of circulating 25-Hydroxyvitamin D and its related genetic variations with hepatocellular carcinoma incidence and survival. Annals of Translational Medicine. 8(17). 1080–1080. 12 indexed citations
14.
Jiang, Guangyi, Chiung‐Kuei Huang, Xinjie Zhang, et al.. (2019). Wnt signaling in liver disease: emerging trends from a bibliometric perspective. PeerJ. 7. e7073–e7073. 6 indexed citations
15.
Sun, Mengqi, Zhiwei Zhao, Na Wei, et al.. (2019). Effect of RhoC silencing on multiple myeloma xenografts and angiogenesis in nude mice.. PubMed. 33(5). 1387–1394. 2 indexed citations
16.
17.
Zheng, Xueyong, et al.. (2018). High expression of ERCC5 predicts a poor prognosis in hepatocellular carcinoma.. PubMed. 11(7). 3664–3670. 6 indexed citations
18.
Chen, Ke, Yu Pan, Xiaolong Liu, et al.. (2017). Minimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery. BMC Gastroenterology. 17(1). 120–120. 62 indexed citations
19.
Jiang, Guangyi, et al.. (2017). Jejunojejunal intussusception after Roux-en-Y gastric bypass in a situs inversus totalis patient. Medicine. 96(15). e6589–e6589. 1 indexed citations
20.
Yu, Jian, Junliang Li, Shanyi Zhang, et al.. (2011). IGF-1 induces hypoxia-inducible factor 1α-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells. Brain Research. 1430. 18–24. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuyoshi Okazaki Breakdown of academic impact, for papers by Annabella Di Mauro Breakdown of academic impact, for papers by Guoxiang Fu Breakdown of academic impact, for papers by Yu–Fu Su Breakdown of academic impact, for papers by Yingwei Zhu Breakdown of academic impact, for papers by Qing Yuan Breakdown of academic impact, for papers by Yunhong Tian Breakdown of academic impact, for papers by Zhijian Ren Breakdown of academic impact, for papers by Alessio Degiovanni Breakdown of academic impact, for papers by Susrutha K. Wickremesekera
Rankless by CCL
2026